Exposure to SSRI Antidepressants In Utero Causes Birth Defects, Neonatal Withdrawal Symptoms, and Brain Damage

Breggin, Peter R.; Breggin, Ginger
March 2008
Ethical Human Psychology & Psychiatry;2008, Vol. 10 Issue 1, p5
Academic Journal
Pregnant mothers should avoid taking SSRI antidepressants--they are hazardous to the developing fetus, cause withdrawal symptoms in the newborn baby, and induce biochemical and morphological abnormalities in the brain. If pregnant mothers need help with sad or anxious feelings, they should seek counseling or psychotherapy, especially family therapy involving the child's father, as well as other sources of emotional support.


Related Articles

  • Prenatal diagnosis of Neu-Laxova syndrome: a case report. Aslan, Halil; Gul, Ahmet; Polat, Ibrahim; Mutaf, Cihan; Agar, Mehmet; Ceylan, Yavuz // BMC Pregnancy & Childbirth;2002, Vol. 2, p1 

    Background: Neu-Laxova syndrome is a rare congenital abnormality involving multiple systems. We report a case of Neu-Laxova syndrome (NLS) diagnosed prenatally by ultrasound examination. Case presentation: A 29-year-old gravida 3, para 2 woman was first seen in our antenatal clinic at 38 weeks'...

  • Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement. Negrato, Carlos Antonio; Montenegro, Jr., Renan M.; Mattar, Rosiane; Zajdenverg, Lenita; Francisco, Rossana P. V.; Pereira, Belmiro Gonçalves; Sancovski, Mauro; Torloni, Maria Regina; Dib, Sergio A.; Viggiano, Celeste E.; Golbert, Airton; Moisés, Elaine C. D.; Favaro, Maria Isabel; Calderon, Iracema M. P.; Fusaro, Sonia; Piliakas, Valeria D. D.; Dias, José Petronio L.; Gomes, Marilia B.; Jovanovic, Lois // Diabetology & Metabolic Syndrome;2010, Vol. 2 Issue 1, p1 

    There is an urgent need to find consensus on screening, diagnosing and treating all degrees of DYSGLYCEMIA that may occur during pregnancies in Brazil, considering that many cases of DYSGLYCEMIA in pregnant women are currently not diagnosed, leading to maternal and fetal complications. For this...

  • Congenital malformation risk with paroxetine.  // Reactions Weekly;10/15/2005, Issue 1073, p2 

    Reports on a Public Health Advisory and a Dear Health Care Professional letter issued by GlaxoSmithKline (GSK) which revealed that exposure to paroxetine in the first trimester of pregnancy may increase the risk of congenital malformations, compared with other antidepressants. Recommendation of...

  • Pregnancy Outcome Following Gestational Exposure to Organic Solvents. Khattak, Sohail; K-Moghtader, Guiti; McMartin, Kristen; Barrera, Maru; Kennedy, Debbie; Koren, Gideon // JAMA: Journal of the American Medical Association;3/24/99, Vol. 281 Issue 12, p1106 

    Presents study to evaluate pregnancy and fetal outcome following maternal occupational exposure to organic solvents. Increased risk for fetal abnormalities; Design Setting; Patients; Main outcomes measure; Results; Conclusions.

  • What Moms Can Do Now. Check, Erika // Newsweek;9/27/1999, Vol. 134 Issue 13, p57 

    Presents health guidelines for pregnant women. Impact of maternal health on fetal development; Preconception care; Meal planning; Food; Weight gain; Use of drugs, caffeine, alcohol and cigarettes; Exercise; Stress; Seat belts; Sexually transmitted diseases.

  • Radioisotopes might carry risk for pregnant laboratory technicians.  // Nursing Standard;2/1/2006, Vol. 20 Issue 21, p19 

    The article reports that exposure of pregnant laboratory technicians to radioisotopes carries a high risk of preterm birth and congenital malformation. In a study, researchers in Denmark compared female laboratory technicians to teachers in terms of pregnancy outcomes. Researchers found that...

  • The experiences of pregnant women diagnosed with a fetal abnormality. Araki, Nao // Journal of Japan Academy of Midwifery;Oct2010, Vol. 24 Issue 2, p358 

    Purpose This paper first focuses on outlining currently available knowledge throughout the world regarding women who decide to continue with their pregnancy knowing that there will be something abnormal about their child. Secondly, it discusses making information applicable to the existing...

  • Selective Serotonin Reuptake Inhibitors Affect Neurobehavioral Development in the Human Fetus. Mulder, Eduard J. H.; Ververs, Frédérique FT; de Heus, Roel; Visser, Gerard H. A. // Neuropsychopharmacology;Sep2011, Vol. 36 Issue 10, p1961 

    The aim of this prospective study was to investigate whether selective serotonin reuptake inhibitors (SSRIs) utilized by pregnant women influence fetal neurobehavioral development. In this observational study we investigated developmental milestones of fetal behavior during the pregnancy of...

  • Effect of different maternal metabolic characteristics on fetal growth in women with gestational diabetes mellitus. Eslamian, Laleh; Akbari, Soheila; Marsoosi, Vajihe; Jamal, Ashraf // Iranian Journal of Reproductive Medicine;Apr2013, Vol. 11 Issue 4, p325 

    Background: Fetal growth in diabetic pregnancies is a complex process and probably abnormalities in other metabolic pathways such as protein and lipid, as well as carbohydrate are responsible for delivering of macrosomic newborn. Objective: The purpose of this study was to investigate the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics